Abstract The quantum dot (QD)-enhanced optical biosensors are very sensitive tools for analyzing single cells. Heavy metal-free alternatives, such as indium phosphide and carbon-based QDs, address safety concerns while achieving high quantum efficiency. Photonic enhancement techniques provide 240-fold signal amplification and quality factors of up to 7000, allowing femtomolar detection limits. However, clinical translation encounters manufacturing scalability and stability problems in complex biological matrices. This review discusses synthetic techniques, surface functionalization, and clinical implementation, highlighting important challenges and potential for improving QD-based biosensors.
Hooshiar et al. (Tue,) studied this question.